WINDTREE THERAPEUTICS INC /DE/ (WINT) Nonoperating Income (Expense) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2024.
  • Windtree Therapeutics Inc /De/ Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $14.7 M, a 18323% increase year-over-year.
  • Windtree Therapeutics Inc /De/ Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $15 M, a 2268% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2023 was $306 K, a 59.6% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2022 was $758 K.
  • Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2021 was -$343 K, a 84.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $15 M $14.7 M +$14.7 M +18323% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $306 K -$195 K +$52 K +21.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $254 K $265 K -$329 K -55.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $583 K $156 K -$49 K -23.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $632 K $80 K -$126 K -61.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $758 K -$247 K -$211 K -586% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $969 K $594 K +$660 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $309 K $205 K +$564 K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$255 K $206 K +$88 K +74.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$343 K -$36 K +$457 K +92.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$800 K -$66 K +$249 K +79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.05 M -$359 K +$1.25 M +77.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.3 M $118 K -$51 K -30.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$2.25 M -$493 K +$2.33 M +82.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$4.58 M -$315 K -$376 K -616% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.2 M -$1.61 M -$1.67 M -2876% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$2.53 M $169 K +$49 K +40.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$2.58 M -$2.82 M +$1.37 M +32.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-03
Q3 2019 -$3.95 M $61 K +$520 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$4.47 M $58 K +$74 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$4.55 M $120 K -$208 K -63.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$4.34 M -$4.19 M -$10.2 M -170% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $5.82 M -$459 K +$190 K +29.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-04-03
Q2 2018 $5.63 M -$16 K +$596 K +97.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-03
Q1 2018 $5.04 M $328 K +$936 K Jan 1, 2018 Mar 31, 2018 10-K 2020-04-03
Q4 2017 $4.1 M $5.97 M +$6.21 M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 -$2.1 M -$649 K -$19 K -3.02% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.08 M -$612 K +$19 K +3.01% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.1 M -$608 K -$426 K -234% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.68 M -$234 K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$630 K +$12.6 M +95.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$631 K +$727 K +53.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$182 K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q3 2015 -$13.3 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.36 M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.